- Human（1）
- Mouse（1）
No data
- His Tag（2）
No data
- HEK293（2）
No data
- Unconjugated（2）
No data
- RUO（2）
No data
- Yes（2）
No data
- 100ug/$360.00
- 1mg/$2380.00
No data
- 100ug/$360.00
- 1mg/$2380.00
No data
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| COL1A1 | Human COL1A1 Protein, His Tag, low endotoxin (MALS verified) |  Human | HEK293 |  | MALSSDS-PAGE | $360.00 100ug |   | ||
| COL1A1 | Mouse COL1A1 Protein, His Tag, low endotoxin (MALS verified) |  Mouse | HEK293 |  | MALSSDS-PAGE | $360.00 100ug | |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| AT-02 | AT-02 | Phase 2 Clinical | Attralus Inc | Immunoglobulin Light-chain Amyloidosis; Amyloidosis | Details |
| Anti-CD33/anti-FcgammaRI bispecific antibody (UCSD) | Phase 1 Clinical | University Of California San Diego | Leukemia, Myeloid, Acute | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Imlifidase | Mac-1 | Approved | Hansamed Inc | Idefirix | EU | Rejection of renal transplantation | Hansa Biopharma Ab | 2020-08-25 | Rejection of renal transplantation; Kidney Diseases; Purpura, Thrombotic Thrombocytopenic; Rejection of organ transplantation; Renal Insufficiency, Chronic; Guillain-Barre Syndrome; Kidney Failure, Chronic | Details |
